Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Scarpa

Showing results (161-170 of 211) with videos related to

Pageof 22
Sort By:
Clinical Rheumatology|March 20, 2020
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical settingLuca Navarini, Luisa Costa, Marco Tasso, et al.
Plos One|July 10, 2020
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohortPaola Di Benedetto, Paola Cipriani, Daniela Iacono, et al.
Rheumatology International|October 13, 2019
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional studyFrancesco Caso, Luca Navarini, Francesco Carubbi, et al.
Rheumatology and Therapy|October 15, 2021
Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational StudyNicolò Girolimetto, Pierluigi Macchioni, Ilaria Tinazzi, et al.
Expert Opinion on Drug Safety|December 8, 2016
Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysisStefanos Bonovas, Silvia Minozzi, Theodore Lytras, et al.
Clinical and Experimental Rheumatology|May 23, 2014
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritisAntonio Spadaro, Ennio Lubrano, Antonio Marchesoni, et al.
Reviews on Recent Clinical Trials|March 16, 2018
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis PatientsRosario Peluso, Francesco Caso, Marco Tasso, et al.
Rheumatology (Oxford, England)|January 6, 2021
Dissecting the clinical heterogeneity of adult-onset Still's disease: results from a multi-dimensional characterization and stratificationOnorina Berardicurti, Alessandro Conforti, Daniela Iacono, et al.
Clinical and Experimental Rheumatology|December 4, 2015
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) studyIgnazio Olivieri, Paolo A Cortesi, Simona de Portu, et al.
Arthritis Research & Therapy|June 24, 2020
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patientsPiero Ruscitti, Onorina Berardicurti, Daniela Iacono, et al.
Pageof 22

Showing results (161-170 of 211) with videos related to

Sort By:
Pageof 22
Clinical Rheumatology|March 20, 2020
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical settingLuca Navarini, Luisa Costa, Marco Tasso, et al.
Plos One|July 10, 2020
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohortPaola Di Benedetto, Paola Cipriani, Daniela Iacono, et al.
Rheumatology International|October 13, 2019
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional studyFrancesco Caso, Luca Navarini, Francesco Carubbi, et al.
Rheumatology and Therapy|October 15, 2021
Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational StudyNicolò Girolimetto, Pierluigi Macchioni, Ilaria Tinazzi, et al.
Expert Opinion on Drug Safety|December 8, 2016
Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysisStefanos Bonovas, Silvia Minozzi, Theodore Lytras, et al.
Clinical and Experimental Rheumatology|May 23, 2014
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritisAntonio Spadaro, Ennio Lubrano, Antonio Marchesoni, et al.
Reviews on Recent Clinical Trials|March 16, 2018
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis PatientsRosario Peluso, Francesco Caso, Marco Tasso, et al.
Rheumatology (Oxford, England)|January 6, 2021
Dissecting the clinical heterogeneity of adult-onset Still's disease: results from a multi-dimensional characterization and stratificationOnorina Berardicurti, Alessandro Conforti, Daniela Iacono, et al.
Clinical and Experimental Rheumatology|December 4, 2015
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) studyIgnazio Olivieri, Paolo A Cortesi, Simona de Portu, et al.
Arthritis Research & Therapy|June 24, 2020
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patientsPiero Ruscitti, Onorina Berardicurti, Daniela Iacono, et al.
Pageof 22